Novo Nordisk | Vermögenswerte



Assets Veränderung Datum
ANI Pharmaceuticals USD 1.28B 3.68M 2024-12
Aurora Cannabis CAD 866.52M 57.75M 2024-12
Bausch Health Companies USD 26.54B 45M 2024-09
Bristol-Myers Squibb USD 92.43B 176M 2025-03
Canopy Growth CAD 1.16B 68.13M 2024-12
Corcept Therapeutics USD 840.55M 56.3M 2024-12
Drreddys Laboratories INR 481.06B 15.1B 2024-12
Eli Lilly USD 78.71B 3.11B 2024-12
GlaxoSmithKline GBP 59.46B 1.41B 2024-12
Merck USD 117.11B 426M 2024-12
Novartis USD 102.25B 1.28B 2024-12
Novo Nordisk 397.44B 28.06B 2024-09
Novo Nordisk DKK 397.44B 28.06B 2024-09
Pacira USD 1.55B 31.82M 2024-12
Perrigo USD 9.65B 1.56B 2024-12
Prestige Brands USD 3.33B 12.61M 2024-12
Sanofi 131.89B 906M 2025-03
Supernus Pharmaceuticals USD 1.37B 25.37M 2024-12
Zoetis USD 14.24B 120M 2024-12



Novo Nordisk Vermögenswerte - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.